Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,173.9
9.1 (0.29%)

 

  • STI Straits Times Index
    3,173.9
    9.1 (0.29%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,598.3
    5.8 (0.36%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,331.0
    368.4 (1.48%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,572.4
    14.1 (0.40%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,068.6
    517.7 (1.81%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,633.3
    7.2 (0.11%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,492.6M
  • Value: 1,237.8M
  • Rise: 199
  • Fall: 127
  • Unch: 425

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.079+0.009
Rex Intl0.310+0.005
Genting Sing0.795+0.015
Ntegrator Intl0.009-
Geo Energy Res0.410-0.010
RH PetroGas0.205-
Sembcorp Marine0.080-
MarcoPolo Marine0.028-0.001
BlackGoldNatural0.019-
ThaiBev0.715+0.005

World Indices

World Indices
Name Last Change
Nasdaq 14,897.3 +73.9
HSI 25,331.0 +368.4
HSCEI 8,966.2 +117.0
Jakarta 6,633.3 +7.2
Nikkei 225 29,068.6 +517.7
SSE Comp 3,572.4 +14.1
Shanghai A 3,743.9 +14.8
Shanghai B 278.0 +0.5
KOSPI 3,015.1 +26.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

MEDIWOUND LTD MEDIWOUND LTD.
Updated on 15 Oct 2021 (End of trading day)
Last (USD): 3.410 Change: +0.010 High: 3.510 Remarks: -
Change (%): +0.29 Low: 3.350
Open 3.440 Yesterday's Close 3.4000000000000004
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 55,233 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.33752 Trailing EPS (USD) e -0.35547 NAV (USD) b 0.0777
PE a - Trailing PE f - Price / NAV b 43.8867
Dividend (USD) d - Cash In Hand (USD) g 0.6304 Issued & Paid-up Shares c 27,245,400
Dividend Yield (%) d - Price / Cash In Hand g 5.409 Treasury Shares h -
Market Cap (M) 92.907 Enterprise Value (M) 79.017
Piotroski F Score 1 Exchange Code MDWD Par Value ( $ ) n.a.
52 Weeks Volatility (%) 78.31 Free Float (%) 91.0
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 11 Aug 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference MEDIWOUND LTD NASDAQ 92.907 - - 43.8867 -
Industry Pharmaceuticals: Major NASDAQ 2,306.550 86.908 91.614 3.3289 0.026
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 186,577.819 58.379 49.477 11.9021 1.928
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 123,441.019 8.794 17.825 1.6460 2.738
Local Peer ROYALTY PHARMA PLC NASDAQ 23,309.333 23.906 23.992 4.0653 0.500
Local Peer VIATRIS INC NASDAQ 16,277.043 - - 0.7675 -
Local Peer REPLIGEN CORP NASDAQ 14,674.514 244.876 146.844 9.1540 -
Local Peer ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS NASDAQ 9,083.592 - - 11.1415 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 7,512.104 - - 22.0997 -
Local Peer CUREVAC NV NASDAQ 7,415.280 - - - -
Local Peer ALLAKOS INC NASDAQ 5,803.544 - - 10.1641 -
Local Peer HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS NASDAQ 5,584.121 - - 5.6703 -
Local Peer CEREVEL THERAPEUTICS HLDGS INC NASDAQ 5,116.808 - - 17.4110 -
Local Peer I MAB SPON ADS EACH REP 2.3 ORD SHS NASDAQ 5,066.448 74.259 74.259 5.8881 -
Other Local Peers GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), IMMUNITYBIO INC (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), ERASCA INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), GENERATION BIO CO (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), PROCAPS GROUP S A (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), ICOSAVAX INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), KRONOS BIO INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), ANNEXON INC (NASDAQ), GH RESEARCH PLC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), PETIQ INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), VERU INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), BEYONDSPRING INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), PHARVARIS NV (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), GRITSTONE BIO INC (NASDAQ), AC IMMUNE SA (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), EVOLUS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), MINK THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), PYXIS ONCOLOGY INC (NASDAQ), CLENE INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), 89BIO INC (NASDAQ), ESSA PHARMA INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), ATHENEX INC (NASDAQ), XOMA CORP (NASDAQ), NEXIMMUNE INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), DURECT CORP (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), HARROW HEALTH INC (NASDAQ), VINCERX PHARMA INC (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), TRICIDA INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), OBSEVA SA (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), IMMUNIC INC (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), INOZYME PHARMA INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), ALZAMEND NEURO INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), NOVAN INC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), POLYPID LTD (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), EYENOVIA INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CLARUS THERAPEUTICS HLDGS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), IMARA INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), YUMANITY THERAPEUTICS INC (NASDAQ), GALECTO INC (NASDAQ), PROPHASE LABS INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), GRAYBUG VISION INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), MANNATECH INC (NASDAQ), ABVC BIOPHARMA INC (NASDAQ), BONE BIOLOGICS CORP (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), RENOVORX INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), BAUDAX BIO INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), SEQLL INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), PASITHEA THERAPEUTICS CORP (NASDAQ), XORTX THERAPEUTICS INC (NASDAQ), DERMATA THERAPEUTICS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), PAINREFORM LTD (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), PETROS PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 424,619.024 28.858 23.899 6.1026 2.467
Global Peer PFIZER INC NYSE 232,621.568 24.191 17.586 3.3212 3.662
Global Peer ELI LILLY AND COMPANY NYSE 227,551.488 36.739 37.484 35.3100 1.244
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 202,860.219 24.982 22.555 3.7538 2.313
Global Peer MERCK & CO INC NYSE 198,282.212 28.057 35.592 5.9555 3.165
Global Peer ABBVIE INC NYSE 193,205.789 42.407 29.322 15.3715 4.422
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 181,403.790 28.152 25.482 17.3508 1.314
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 129,682.340 - - 3.5232 3.184
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 98,144.089 13.313 16.547 4.6202 5.304
Global Peer WUXI APPTEC CO LTD HKEx 488,672.596 147.237 105.525 11.0692 0.213
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMACEUTICAL GROUP CO LTD (HKEx), INNOVENT BIOLOGICS INC (HKEx), CANSINO BIOLOGICS INC (HKEx), ORGANON & CO (NYSE), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), SINOPHARM GROUP CO. LTD. (HKEx), REMEGEN CO LTD (HKEx), SHANGHAI PHARMACEUTICALS HOLDING CO (HKEx), HYGEIA HEALTHCARE HLDGS CO LTD (HKEx), HUTCHMED (CHINA) LIMITED (HKEx), SHANGHAI JUNSHI BIOSCIENCES CO LTD (HKEx), AKESO INC (HKEx), CHINA MEDICAL SYSTEM HLDGS LTD (HKEx), GUANGZHOU BAIYUNSHAN PHARMACEUTICAL (HKEx), INNOCARE PHARMA LTD (HKEx), CARSGEN THERAPEUTICS HLDGS LTD (HKEx), CHINA RESOURCES PHARMACEUTICAL GR (HKEx), CHINA GRAND PHARMACEUTICAL & HEALTH (HKEx), EMERGENT BIOSOLUTIONS INC (NYSE), SIMCERE PHARMACEUTICAL GRP LTD (HKEx), CHINA TRADITIONAL CHINESE MED HLDGS (HKEx), ADC THERAPEUTICS SA (NYSE), SHANGHAI HENLIUS BIOTECH INC (HKEx), EVEREST MEDICINES LTD (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), SHENZHEN HEPALINK PHARMACEUTICAL (HKEx), SSY GROUP LIMITED (HKEx), OCUMENSION THERAPEUTICS (HKEx), CSTONE PHARMACEUTICALS (HKEx), UNITED LABORATORIES INTL HLDGS LTD (HKEx), ZYMEWORKS INC (NYSE), ABBISKO CAYMAN LTD (HKEx), Kimia Farma Tbk. (IDX), BEIJING TONG REN TANG CHINESE MEDIC (HKEx), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), IMMUNOTECH BIOPHARM LTD (HKEx), SCICLONE PHARMACEUTICALS (HLDGS) LT (HKEx), CK LIFE SCIENCES INTL HLDG (HKEx), ANTENGENE CORP LTD (HKEx), TRANSCENTA HOLDING LTD (HKEx), CHINA SHINEWAY PHARMACEUTICAL GR (HKEx), HUA MEDICINE (HKEx), ZHAOKE OPHTHALMOLOGY LTD (HKEx), Soho Global Health Tbk. (IDX), IGBB (Bursa), STARPHARMA HOLDINGS LIMITED (ASX), RACE ONCOLOGY LTD (ASX), PYC THERAPEUTICS LIMITED (ASX), TOT BIOPHARM INTL CO LTD (HKEx), DAWNRAYS PHARMACEUTICAL HLDGS (HKEx), CYBIN INC (NYSE American), AFT PHARMACEUTICALS LTD (ASX), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), BSTEAD (Bursa), FUSEN PHARMACEUTICAL CO LTD (HKEx), PHARMA (Bursa), ANNOVIS BIO INC (NYSE American), IP (SET), CHINA BIOTECH SERVICES HLDGS LTD (HKEx), IX Biopharma (SGX), ZHONGZHI PHARMACEUTICAL HLDGS LTD (HKEx), RECCE PHARMACEUTICALS LTD (ASX), Merck Tbk. (IDX), NOXOPHARM LTD (ASX), LANNETT CO INC (NYSE), KOTRA (Bursa), CRESO PHARMA LTD (ASX), CHARMACY PHARMACEUTICAL CO LTD (HKEx), NEW RAY MEDICINE INTL HLDG LTD (HKEx), Phapros Tbk. (IDX), SANAI HEALTH INDUSTRY GP CO LTD (HKEx), NEW CENTURY HEALTHCARE HLDGS CO LTD (HKEx), PAK FAH YEOW INTERNATIONAL (HKEx), Hyphens Pharma (SGX),